Skip to main content
SpringerLink
Log in

The business case for cell and gene therapies

  • Correspondence
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ylä-Herttuala, S. Mol. Ther. 20, 1831–1832 (2012).

    Article  Google Scholar 

  2. Xin, H. Science 314, 1233 (2006).

    Article  Google Scholar 

  3. Brennan, T.A. & Wilson, J.M. Nat. Biotechnol. 32, 874–876 (2014).

    Article  CAS  Google Scholar 

  4. Cook, J.P., Vernon, J.A. & Manning, R. Pharmacoeconomics 26, 551–556 (2008).

    Article  Google Scholar 

  5. Neumann, P.J., Chambers, J.D., Simon, F. & Meckley, L.M. Health Aff. (Millwood) 30, 2329–2337 (2011).

    Article  Google Scholar 

  6. Candotti, F. et al. Blood 120, 3635–3646 (2012).

    Article  CAS  Google Scholar 

  7. Faulkner, E. et al. Value Health 15, 1162–1171 (2012).

    Article  Google Scholar 

  8. Abou-El-Enein, M. et al. Cytotherapy 15, 362–383 (2013).

    Article  Google Scholar 

  9. Abou-El-Enein, M., Bauer, G., Reinke, P., Renner, M. & Schneider, C.K. Trends Mol. Med. 20, 632–642 (2014).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Berlin-Brandenburg Center for Regenerative Therapies, Charité University Medicine, Campus Virchow, Berlin, Germany

    Mohamed Abou-El-Enein & Petra Reinke

  2. Department of Nephrology and Internal Intensive Care, Charité University Medicine, Campus Virchow, Berlin, Germany

    Mohamed Abou-El-Enein & Petra Reinke

  3. University of California, Davis, Institute For Regenerative Cures, Sacramento, California, USA

    Gerhard Bauer

Authors
  1. Mohamed Abou-El-Enein
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gerhard Bauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Petra Reinke
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mohamed Abou-El-Enein.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abou-El-Enein, M., Bauer, G. & Reinke, P. The business case for cell and gene therapies. Nat Biotechnol 32, 1192–1193 (2014). https://doi.org/10.1038/nbt.3084

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.3084

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation